| Mrs Beverly Anita Garrett, | |
|
2105 East South Blvd, Montgomery, AL 36116 | |
| (334) 288-2100 | |
| Not Available |
| Full Name | Mrs Beverly Anita Garrett |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 20 Years |
| Location | 2105 East South Blvd, Montgomery, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962445650 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 1102978 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Medical Center South | Montgomery, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Usa Health Anesthesia Billing Services Llc | 1153659123 | 136 |
| Premier Anesthesia Of Montgomery Pc | 5799684148 | 58 |
News Archive
Calixa Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, will present pre-clinical and clinical data in 20 posters at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) that is being held in San Francisco on September 12 to 15, 2009.
In Connecticut, the board overseeing the development of the state's exchange is already under fire from consumer advocates. Meanwhile, in Kansas, representatives from the health industry are actively involved in the planning processes.
CTI BioPharma Corp. and Servier today announced that the pivotal Phase III study evaluating PIXUVRI® combined with rituximab in comparison to gemcitabine combined with rituximab in patients with aggressive B-cell non-Hodgkin lymphoma did not meet its primary endpoint of improvement of progression-free survival
According to a coroner in Quebec a severe asthma attack was responsible for the death of a 15 year old girl last November and not a peanut-contaminated kiss.
Teva Pharmaceutical Industries Ltd. today reported results for the quarter and year ended December 31, 2011.
› Verified 6 days ago
| Entity Name | Premier Anesthesia Of Montgomery Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780636233 PECOS PAC ID: 5799684148 Enrollment ID: O20040105000491 |
News Archive
Calixa Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, will present pre-clinical and clinical data in 20 posters at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) that is being held in San Francisco on September 12 to 15, 2009.
In Connecticut, the board overseeing the development of the state's exchange is already under fire from consumer advocates. Meanwhile, in Kansas, representatives from the health industry are actively involved in the planning processes.
CTI BioPharma Corp. and Servier today announced that the pivotal Phase III study evaluating PIXUVRI® combined with rituximab in comparison to gemcitabine combined with rituximab in patients with aggressive B-cell non-Hodgkin lymphoma did not meet its primary endpoint of improvement of progression-free survival
According to a coroner in Quebec a severe asthma attack was responsible for the death of a 15 year old girl last November and not a peanut-contaminated kiss.
Teva Pharmaceutical Industries Ltd. today reported results for the quarter and year ended December 31, 2011.
› Verified 6 days ago
| Entity Name | University Of South Alabama |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417408659 PECOS PAC ID: 3072425149 Enrollment ID: O20170118001161 |
News Archive
Calixa Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, will present pre-clinical and clinical data in 20 posters at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) that is being held in San Francisco on September 12 to 15, 2009.
In Connecticut, the board overseeing the development of the state's exchange is already under fire from consumer advocates. Meanwhile, in Kansas, representatives from the health industry are actively involved in the planning processes.
CTI BioPharma Corp. and Servier today announced that the pivotal Phase III study evaluating PIXUVRI® combined with rituximab in comparison to gemcitabine combined with rituximab in patients with aggressive B-cell non-Hodgkin lymphoma did not meet its primary endpoint of improvement of progression-free survival
According to a coroner in Quebec a severe asthma attack was responsible for the death of a 15 year old girl last November and not a peanut-contaminated kiss.
Teva Pharmaceutical Industries Ltd. today reported results for the quarter and year ended December 31, 2011.
› Verified 6 days ago
| Entity Name | Usa Health Anesthesia Billing Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629635818 PECOS PAC ID: 1153659123 Enrollment ID: O20190829000530 |
News Archive
Calixa Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, will present pre-clinical and clinical data in 20 posters at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) that is being held in San Francisco on September 12 to 15, 2009.
In Connecticut, the board overseeing the development of the state's exchange is already under fire from consumer advocates. Meanwhile, in Kansas, representatives from the health industry are actively involved in the planning processes.
CTI BioPharma Corp. and Servier today announced that the pivotal Phase III study evaluating PIXUVRI® combined with rituximab in comparison to gemcitabine combined with rituximab in patients with aggressive B-cell non-Hodgkin lymphoma did not meet its primary endpoint of improvement of progression-free survival
According to a coroner in Quebec a severe asthma attack was responsible for the death of a 15 year old girl last November and not a peanut-contaminated kiss.
Teva Pharmaceutical Industries Ltd. today reported results for the quarter and year ended December 31, 2011.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Beverly Anita Garrett, Po Box 235022, Montgomery, AL 36123-5022 Ph: (334) 386-2051 | Mrs Beverly Anita Garrett, 2105 East South Blvd, Montgomery, AL 36116 Ph: (334) 288-2100 |
News Archive
Calixa Therapeutics Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, will present pre-clinical and clinical data in 20 posters at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) that is being held in San Francisco on September 12 to 15, 2009.
In Connecticut, the board overseeing the development of the state's exchange is already under fire from consumer advocates. Meanwhile, in Kansas, representatives from the health industry are actively involved in the planning processes.
CTI BioPharma Corp. and Servier today announced that the pivotal Phase III study evaluating PIXUVRI® combined with rituximab in comparison to gemcitabine combined with rituximab in patients with aggressive B-cell non-Hodgkin lymphoma did not meet its primary endpoint of improvement of progression-free survival
According to a coroner in Quebec a severe asthma attack was responsible for the death of a 15 year old girl last November and not a peanut-contaminated kiss.
Teva Pharmaceutical Industries Ltd. today reported results for the quarter and year ended December 31, 2011.
› Verified 6 days ago
Mrs. Amanda Marie Haigler, DNP CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1725 Pine St, Montgomery, AL 36106 Phone: 334-293-8000 | |
Crista Wanda Marquardt, C.R.N.A. Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2105 E South Blvd, Montgomery, AL 36116 Phone: 334-288-2100 | |
Andrew Easterling, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1725 Pine St, Montgomery, AL 36106 Phone: 334-279-1450 Fax: 334-395-4115 | |
James Cowell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1725 Pine St, Montgomery, AL 36106 Phone: 334-293-8000 | |
Thomas H. Booth Ii, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2105 E South Blvd, Montgomery, AL 36116 Phone: 334-386-3579 | |
Susan Hamilton Mitchell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2105 E South Blvd, Montgomery, AL 36116 Phone: 334-288-2100 | |
Hollie Nicole Sanders, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2105 E South Blvd, Baptist Hospital Dept Of Anes, Montgomery, AL 36116 Phone: 770-643-5619 |